1/31
03:07 pm
abt
Abbott Laboratories (NYSE:ABT) Posts Q4 Sales In Line With Estimates [Yahoo! Finance]
Low
Report
Abbott Laboratories (NYSE:ABT) Posts Q4 Sales In Line With Estimates [Yahoo! Finance]
1/31
07:00 am
abt
Abbott Laboratories (NYSE: ABT) was upgraded by analysts at Argus to a "strong-buy" rating.
Low
Report
Abbott Laboratories (NYSE: ABT) was upgraded by analysts at Argus to a "strong-buy" rating.
1/30
11:31 am
abt
Ibuprofen API Global Market Analysis/Forecast Report 2024-2030: Focus on Fast-Acting and Extended-Release Formulations, Rising Global Pharmaceutical Outsourcing Creates Opportunities for Producers [Yahoo! Finance]
Low
Report
Ibuprofen API Global Market Analysis/Forecast Report 2024-2030: Focus on Fast-Acting and Extended-Release Formulations, Rising Global Pharmaceutical Outsourcing Creates Opportunities for Producers [Yahoo! Finance]
1/27
08:01 am
abt
Abbott Laboratories (NYSE: ABT) had its "overweight" rating re-affirmed by analysts at Barclays PLC. They now have a $158.00 price target on the stock, up previously from $149.00.
Medium
Report
Abbott Laboratories (NYSE: ABT) had its "overweight" rating re-affirmed by analysts at Barclays PLC. They now have a $158.00 price target on the stock, up previously from $149.00.
1/27
06:00 am
abt
Is There More Upside For ABT Stock After A 10% Jump In A Week? [Forbes]
Low
Report
Is There More Upside For ABT Stock After A 10% Jump In A Week? [Forbes]
1/26
10:12 am
abt
Here's what we'd like to see from our 8 stocks reporting earnings this week [CNBC]
Medium
Report
Here's what we'd like to see from our 8 stocks reporting earnings this week [CNBC]
1/24
08:21 pm
abt
Lightning Round: I prefer SoFi to Nu Holdings, says Jim Cramer [CNBC]
Medium
Report
Lightning Round: I prefer SoFi to Nu Holdings, says Jim Cramer [CNBC]
1/24
07:11 pm
abt
Cramer's Lightning Round: ‘I'm worried about Wendy's' [CNBC]
Medium
Report
Cramer's Lightning Round: ‘I'm worried about Wendy's' [CNBC]
1/24
12:41 am
abt
Abbott Laboratories (ABT) Q4 2024 Earnings Call Transcript [Yahoo! Finance]
Low
Report
Abbott Laboratories (ABT) Q4 2024 Earnings Call Transcript [Yahoo! Finance]
1/23
09:28 am
abt
Abbott Laboratories (NYSE: ABT) had its price target raised by analysts at Stifel Nicolaus from $130.00 to $135.00. They now have a "buy" rating on the stock.
Medium
Report
Abbott Laboratories (NYSE: ABT) had its price target raised by analysts at Stifel Nicolaus from $130.00 to $135.00. They now have a "buy" rating on the stock.
1/23
09:28 am
abt
Abbott Laboratories (NYSE: ABT) had its price target raised by analysts at Wells Fargo & Company from $133.00 to $136.00. They now have an "overweight" rating on the stock.
Medium
Report
Abbott Laboratories (NYSE: ABT) had its price target raised by analysts at Wells Fargo & Company from $133.00 to $136.00. They now have an "overweight" rating on the stock.
1/23
09:07 am
abt
Abbott Laboratories (NYSE: ABT) had its price target raised by analysts at UBS Group AG from $146.00 to $148.00. They now have a "buy" rating on the stock.
Medium
Report
Abbott Laboratories (NYSE: ABT) had its price target raised by analysts at UBS Group AG from $146.00 to $148.00. They now have a "buy" rating on the stock.
1/22
11:26 am
abt
Organic Baby Food Market Surges to USD 11.42 Billion by 2030, Propelled by 12.24% CAGR - Verified Market Reports® [Yahoo! Finance]
Low
Report
Organic Baby Food Market Surges to USD 11.42 Billion by 2030, Propelled by 12.24% CAGR - Verified Market Reports® [Yahoo! Finance]
1/22
10:31 am
abt
Abbott Labs Q4 Earnings And Q1 Profit Guidance Lags Street View, Worldwide COVID-19 Testing Sales Fall [Yahoo! Finance]
Low
Report
Abbott Labs Q4 Earnings And Q1 Profit Guidance Lags Street View, Worldwide COVID-19 Testing Sales Fall [Yahoo! Finance]
1/22
10:31 am
abt
Abbott Laboratories Posts 'Middling' Quarter, But Diabetes Devices Shine [Yahoo! Finance]
Low
Report
Abbott Laboratories Posts 'Middling' Quarter, But Diabetes Devices Shine [Yahoo! Finance]
1/22
10:09 am
abt
Abbott Laboratories Stock Falls After Earnings as Sales Miss Estimates [Yahoo! Finance]
Low
Report
Abbott Laboratories Stock Falls After Earnings as Sales Miss Estimates [Yahoo! Finance]
1/22
08:58 am
abt
Abbott Laboratories Slides On Light Fourth-Quarter Sales, In-Line Profit [Yahoo! Finance]
Low
Report
Abbott Laboratories Slides On Light Fourth-Quarter Sales, In-Line Profit [Yahoo! Finance]
1/22
07:53 am
abt
Abbott Laboratories slips after Q4 topline miss [Seeking Alpha]
Medium
Report
Abbott Laboratories slips after Q4 topline miss [Seeking Alpha]
1/22
07:51 am
abt
Abbott Reports Fourth-Quarter and Full-Year 2024 Results; Issues 2025 Financial Outlook [Yahoo! Finance]
Medium
Report
Abbott Reports Fourth-Quarter and Full-Year 2024 Results; Issues 2025 Financial Outlook [Yahoo! Finance]
1/22
07:34 am
abt
Abbott in charts: Medical Devices sales reach all-time high in Q4 [Seeking Alpha]
Medium
Report
Abbott in charts: Medical Devices sales reach all-time high in Q4 [Seeking Alpha]
1/22
07:27 am
abt
Earnings Snapshot: Abbott Laboratories Q4 misses revenue estimates; initiates Q1 and FY25 outlook [Seeking Alpha]
Low
Report
Earnings Snapshot: Abbott Laboratories Q4 misses revenue estimates; initiates Q1 and FY25 outlook [Seeking Alpha]
1/22
07:05 am
abt
Abbott Laboratories Non-GAAP EPS of $1.34 in-line, revenue of $11B misses by $30M [Seeking Alpha]
Low
Report
Abbott Laboratories Non-GAAP EPS of $1.34 in-line, revenue of $11B misses by $30M [Seeking Alpha]
1/22
07:00 am
abt
Abbott Reports Fourth-Quarter and Full-Year 2024 Results; Issues 2025 Financial Outlook
Medium
Report
Abbott Reports Fourth-Quarter and Full-Year 2024 Results; Issues 2025 Financial Outlook
1/21
12:19 pm
abt
Abbott Laboratories (NYSE: ABT) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $135.00 price target on the stock.
Low
Report
Abbott Laboratories (NYSE: ABT) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $135.00 price target on the stock.
1/21
11:30 am
abt
Body Area Network Business Research Report 2024: Global Market to Reach $131 Billion by 2030, Fueled by Expansion of IoT-Enabled Wearables in Consumer and Medical [Yahoo! Finance]
Low
Report
Body Area Network Business Research Report 2024: Global Market to Reach $131 Billion by 2030, Fueled by Expansion of IoT-Enabled Wearables in Consumer and Medical [Yahoo! Finance]